Company Profile

Corporate Overview
Board of Directors
Management Team
Scientific Advisory Board

Technology

CNO Technology
Worldwide Patent

Products

VACNO

HemoZyme
Other Products
Licensing Opportunity

News & Releases

News
Scientific Publications

Contact Us
Home
DERMOZYMEÒ

DermoZymeÒ is a skin specific antioxidant enzyme mimetic cream that offers a unique approach for the topical treatment of common skin disorders that have cellular oxidative damage as a key factor in their pathophysiology. Oxidative damage by free radicals is implicated in the hyper-inflammatory processes in psoriasis, as well as in premature skin aging and skin malignancies. Chronic exposure to UV radiation produces photoaging of the skin that is characterized by wrinkles, mottled pigmentation, loss of skin tone, telangiectasia and laxity. Other environmental factors that contribute to skin aging include smoking and environmental pollutants which produce free radicals that damage cell membranes. Cigarette smoking, particularly in women, exacerbates the photoaging process and increases the incidence of skin cancers.  DermoZymeÒ may also prove effective in reducing skin cancer and other problems caused by radiation damage and in reducing the inflammation associated with cryosurgery.


Home | Corporate Profile | Technology | Products | News & Releases | Contact Us